Rare Diseases
FDA approves ANDA of 20mg generic Nitisinone capsules
June 1, 2023Medical Communications Analog Pharma, Dipharma, FDA, Nitisinone, Rare Diseases
Analog Pharma and Dipharma have announced that the US Food and Drug Administration (FDA) has approved their 20mg nitisinone capsules, …
Boehringer Ingelheim and Ginkgo Bioworks collaborate over $406m undruggable targets deal
May 9, 2023Research and Development Boehringer Ingelheim, Rare Diseases, cell programming, ginkgo bioworks, undruggable targets
German pharmaceutical company Boehringer Ingelheim (BI) and cell programming and biosecurity platform builder Ginkgo Bioworks have announced a partnership to …
Maze Therapeutics and Sanofi sign exclusive worldwide license agreement for Pompe disease treatment
May 3, 2023Sales and Marketing License Agreement, Pompe disease, Rare Diseases, Sanofi, maze therapeutics, treatment
Maze Therapeutics and Sanofi have announced that they have signed an exclusive worldwide license agreement for Maze’s gluogen synthase 1 …
